Vanin E F, Kaloss M, Broscius C, Nienhuis A W
Genetic Therapy Inc., Gaithersburg, Maryland 20878.
J Virol. 1994 Jul;68(7):4241-50. doi: 10.1128/JVI.68.7.4241-4250.1994.
Rapidly progressive T-cell lymphomas were observed in 3 of 10 rhesus monkeys several months after autologous transplantation of enriched bone marrow stem cells that had been transduced with a retroviral vector preparation containing replication-competent virus (R. E. Donahue, S. W. Kessler, D. Bodice, K. McDonagh, C. Dunbar, S. Goodman, B. Agricola, E. Byrne, M. Raffeld, R. Moen, J. Bacher, K. M. Zsebo, and A. W. Nienhuis, J. Exp. Med. 176:1124-1135, 1992). The animals with lymphoma appeared to be tolerant to retroviral antigens in that their sera lacked antibodies reactive with viral proteins and contained 10(4) to 10(5) infectious virus particles per ml. By molecular cloning and DNA sequencing, we have now demonstrated that the serum from one of the monkeys contained a replication-competent retrovirus that arose by recombination between vector and packaging encoding sequences (vector/helper [V/H] recombinant) in the producer clone used for transduction of bone marrow stem cells. Southern blot analysis demonstrated 14 or 25 copies of this genome per cell where present in two animals. The genome of a second replication-competent virus was also recovered by molecular cloning; it arose by recombination involving the genome of the V/H recombinant and endogenous murine retroviral genomes in the producer clone. Twelve copies of this amphotropic virus/mink cell focus-forming virus genome were present in tumor DNA of one animal, but it was not found in tumor DNA of the other two animals with lymphoma. Southern blot analysis of DNA from various tissues demonstrated common insertion site bands in several samples of tumor DNA from one animal, suggesting clonal origin of the lymphoma. Our data are most consistent with a pathogenic mechanism in which chronic productive retroviral infection allowed insertional mutagenesis of critical growth control genes, leading to cell transformation and clonal tumor evolution.
在10只恒河猴中的3只接受富含骨髓干细胞的自体移植数月后,观察到快速进展的T细胞淋巴瘤。这些干细胞是用含有复制能力病毒的逆转录病毒载体制剂转导的(R.E.多纳休、S.W.凯斯勒、D.博迪斯、K.麦克多纳、C.邓巴、S.古德曼、B.阿格里科拉、E.伯恩、M.拉费尔德、R.莫恩、J.巴赫、K.M.泽博和A.W.尼恩huis,《实验医学杂志》176:1124 - 1135,1992)。患有淋巴瘤的动物似乎对逆转录病毒抗原具有耐受性,因为它们的血清缺乏与病毒蛋白反应的抗体,并且每毫升含有10⁴至10⁵个感染性病毒颗粒。通过分子克隆和DNA测序,我们现在已经证明,其中一只猴子的血清含有一种复制能力的逆转录病毒,它是由用于转导骨髓干细胞的生产克隆中的载体和包装编码序列之间的重组产生的(载体/辅助[V/H]重组体)。Southern印迹分析表明,在两只动物中,每个细胞存在14或25个这种基因组拷贝。通过分子克隆还回收了第二种具有复制能力病毒的基因组;它是由涉及生产克隆中V/H重组体基因组和内源性鼠逆转录病毒基因组的重组产生的。在一只动物的肿瘤DNA中存在12个这种嗜异性病毒/貂细胞集落形成病毒基因组拷贝,但在另外两只患有淋巴瘤的动物的肿瘤DNA中未发现。对来自各种组织的DNA进行Southern印迹分析表明,来自一只动物的几个肿瘤DNA样本中存在共同的插入位点条带,提示淋巴瘤的克隆起源。我们的数据与一种致病机制最为一致,即慢性持续性逆转录病毒感染允许关键生长控制基因发生插入诱变,导致细胞转化和克隆性肿瘤进化。